Dr Jade Pollock

Lecturer Grade

Department of Life and Health Sciences

North Building

| Room: 222

[email protected]

+353 (0)42 9370200

Teaching

BSc in Bioscience

Course type: Undergraduate

Study mode: Full-Time

Duration: 3 Years

Start date: Sep 2025

BSc (Hons) in Biopharmaceutical Science

Course type: Add On

Study mode: Full-Time

Duration: 1 Year

Start date: Sep 2025

MSc / Postgraduate Diploma in Agricultural Biotechnology

Course type: Postgraduate

Study mode: Full-Time|Part-Time

Duration: 1-2 Years

Start date: Sep 2025

BSc in Veterinary Nursing

Course type: Undergraduate

Study mode: Full-Time

Duration: 3 Years

Start date: Sep 2025

BSc (Hons) in Advanced Veterinary Nursing

Course type: Add On

Study mode: Full-Time|Part-Time

Duration: 1 - 2 years

Start date: Sep 2025

Publications

The publications listed below represent my 7 most recent works as recorded on ORCiD

SURE (science undergraduate research experience)
17 December 2024
Type: Journal article

Investigational new drugs
19 February 2018
DOI: 10.1007/s10637-017-0543-z
Type: Journal article

Bioorganic & medicinal chemistry
29 June 2016
DOI: 10.1016/j.bmc.2016.06.050
Type: Journal article

Investigational new drugs
17 February 2016
DOI: 10.1007/s10637-016-0331-1
Type: Journal article

Journal of medicinal chemistry
17 December 2015
DOI: 10.1021/acs.jmedchem.5b01086
Type: Journal article

Journal of medicinal chemistry
17 November 2014
DOI: 10.1021/jm500670d
Type: Journal article

Biochemical pharmacology
22 October 2014
DOI: 10.1016/j.bcp.2014.10.002
Type: Journal article

Dr Jade Pollock

Teaching

BSc in Bioscience

BSc (Hons) in Biopharmaceutical Science

MSc / Postgraduate Diploma in Agricultural Biotechnology

BSc in Veterinary Nursing

BSc (Hons) in Advanced Veterinary Nursing

Publications

Investigating the Expression of c-Myc and BIRC5 in TRAIL and PBOX-15 treated Metastatic Prostate Cancer Cells Investigating the Expression of c-Myc and BIRC5 in TRAIL and PBOX-15 treated Metastatic Prostate Cancer Cells

Involvement of NF-κB in mediating the anti-tumour effects of combretastatins in T cells. Involvement of NF-κB in mediating the anti-tumour effects of combretastatins in T cells.

Synthesis, antiproliferative and pro-apoptotic activity of 2-phenylindoles. Synthesis, antiproliferative and pro-apoptotic activity of 2-phenylindoles.

Synthesis and Biochemical Evaluation of 3-Phenoxy-1,4-diarylazetidin-2-ones as Tubulin-Targeting Antitumor Agents. Synthesis and Biochemical Evaluation of 3-Phenoxy-1,4-diarylazetidin-2-ones as Tubulin-Targeting Antitumor Agents.

β-Lactam estrogen receptor antagonists and a dual-targeting estrogen receptor/tubulin ligand. β-Lactam estrogen receptor antagonists and a dual-targeting estrogen receptor/tubulin ligand.

Combretastatin (CA)-4 and its novel analogue CA-432 impair T-cell migration through the Rho/ROCK signalling pathway. Combretastatin (CA)-4 and its novel analogue CA-432 impair T-cell migration through the Rho/ROCK signalling pathway.